European Union Expands Kalydeco’s Approval to Certain CF Patients Ages 1-2
Kalydeco (ivacaftor) by Vertex Pharmaceuticals has been approved in the European Union for children ages 1-2 with cystic fibrosis (CF)...
Cystic Fibrosis Patients Exposed to Higher Risks of Liver Cancer
Researchers from Colorado, in the United States, shared the results of a study that showed that patients with cystic fibrosis would be at...
New Mucus Study Could Hold the Key to Clearing Your Phlegm
Mucus, you fickle fiend—usually, you’re there keeping us safe from whatever nasties sneak inside of us. But then you turn, becoming a...
New Test of Mucus Properties May Help with Coughing and Airway Clearance in CF
A new test was able to assess various properties of the mucus that accumulates in the lungs of people with cystic fibrosis and other...
Avycaz May Be Effective for Multidrug-resistant P. aeruginosa Infections in CF Patients, Study Sugge
Antibacterial Avycaz (ceftazidime-avibactam) showed significant in vitroefficacy against multidrug-resistant Pseudomonas aeruginosa...
Ultrasound Predicts Advanced Liver Disease in CF Patients, According to Clinical Trial Data
Ultrasound may predict liver disease in young cystic fibrosis (CF) patients, according to the results of a clinical trial. Researchers...
New cystic fibrosis drugs significantly improve lung function
A triple drug combination for treating the underlying cause of cystic fibrosis is currently under study. The preliminary results show a...
Law Student returned to life with lung transplantation
Law student came back to life with lung transplantation, 20 years of law student struggles with genetic disease ISTANBUL – For many...
The Bittersweet Downside of CFTR Modulators
I’ve been on Orkambi (lumacaftor/ivacaftor), a cystic fibrosis transmembrane conductance regulator (CFTR) modulator, for just over three...
#NACFC2018 – RPL554 Shows Promising Results in CF Studies
Positive data from preclinical and Phase 2a studies evaluating the investigational cystic fibrosis (CF) treatment RPL554 were presented...
